切口负压伤口治疗预防手术部位感染:系统评价与Meta分析
iNPWT与总体手术部位感染(SSI)风险降低相关(RR 0.64,95%CI 0.57-0.72),但也增加皮肤水疱和器械相关不良事件风险。证据支持选择性而非常规使用iNPWT。
要点
- iNPWT降低总体SSI风险,NNT为21,证据确定性中等。
- iNPWT增加皮肤水疱(RR 4.51)和器械相关不良事件(RR 11.87)风险。
- 建议对切口并发症高风险患者选择性使用iNPWT,而非常规使用。
核心结论
- 在85项RCT的Meta分析中,iNPWT与总体、深部和浅表SSI及多种伤口并发症风险降低相关,但皮肤水疱和器械相关不良事件风险可能升高。
- 证据支持选择性而非常规使用iNPWT,尤其适用于切口伤口并发症风险升高的患者。
研究设计与样本
- 系统评价与Meta分析,检索PubMed、Embase和Cochrane CENTRAL从建库至2026年3月7日。
- 采用随机效应模型合并风险比(RR)和均数差及95%CI。
主要发现
- iNPWT组总体SSI风险较低(RR 0.64;95%CI 0.57-0.72),深部SSI(RR 0.66;95%CI 0.51-0.86)和浅表SSI(RR 0.59;95%CI 0.49-0.72)风险亦较低。
- iNPWT组伤口裂开(RR 0.73;95%CI 0.61-0.88)、血清肿(RR 0.77;95%CI 0.63-0.94)、再手术(RR 0.80;95%CI 0.64-0.99)和皮肤坏死(RR 0.38;95%CI 0.18-0.80)风险较低。
- 器官腔隙SSI、再入院和死亡率无显著差异。
- iNPWT组皮肤水疱(RR 4.51;95%CI 2.37-8.58)和器械相关不良事件(RR 11.87;95%CI 4.74-29.74)风险较高。
- SSI的NNT为21;皮肤水疱的NNH为18,器械相关不良事件的NNH为11;试验序贯分析证实总体、深部和浅表SSI的证据;证据确定性为中等。
临床怎么用
- 对于切口伤口并发症高风险的患者,可考虑选择性使用iNPWT以降低SSI风险。
- 使用iNPWT时应监测皮肤水疱和器械相关不良事件,尤其注意NNH较低(皮肤水疱NNH 18,器械相关不良事件NNH 11)。
- 不建议在所有手术患者中常规使用iNPWT,需权衡SSI预防获益与器械相关伤害风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Incisional negative pressure wound therapy (iNPWT) has been proposed as a nonantibiotic adjunct to standard dressings for preventing surgical site infection (SSI), but uncertainty remains regarding consistency across SSI subtypes and dressing-related harms. OBJECTIVE: To evaluate the efficacy and safety of iNPWT vs standard dressing in adults undergoing surgery. DATA SOURCES: PubMed, Embase, and Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception through March 7, 2026. STUDY SELECTION: Randomized clinical trials (RCTs) enrolling adults in whom iNPWT was applied to primarily closed surgical incisions and compared with standard dressing. DATA EXTRACTION AND SYNTHESIS: Two reviewers independently extracted data. Risk ratios (RRs) and mean differences with 95% CIs were pooled using random-effects models. MAIN OUTCOMES AND MEASURES: The primary outcome was overall SSI. Secondary outcomes included SSI subtypes, wound dehiscence, seroma, skin necrosis, reoperation, readmission, mortality, skin blistering, and device-related adverse events. RESULTS: Eighty-five RCTs comprising 16 980 patients (iNPWT, n = 8463; standard dressing, n = 8517) were included. The mean (SD) age was 48.3 (19.4) years (48.1 [19.5] years in the iNPWT group and 48.5 [19.4] years in the standard dressing group), and 5660 of 16 075 individuals (35.2%) were male (2889 [35.7%] in the iNPWT group and 2771 [34.7%] in the standard dressing group). iNPWT was associated with lower risk of overall SSI (RR, 0.64; 95% CI, 0.57-0.72), deep SSI (RR, 0.66; 95% CI, 0.51-0.86), superficial SSI (RR, 0.59; 95% CI, 0.49-0.72), wound dehiscence (RR, 0.73; 95% CI, 0.61-0.88), seroma (RR, 0.77; 95% CI, 0.63-0.94), reoperation (RR, 0.80; 95% CI, 0.64-0.99), and skin necrosis (RR, 0.38; 95% CI, 0.18-0.80). No significant differences were observed for organ-space SSI, readmission, or mortality. iNPWT was associated with higher risks of skin blistering (RR, 4.51; 95% CI, 2.37-8.58) and device-related adverse events (RR, 11.87; 95% CI, 4.74-29.74). The number needed to treat was 21 for SSI; the number needed to harm was 18 for skin blistering and 11 for device-related adverse events. Trial sequential analysis confirmed evidence for overall, deep, and superficial SSI. Certainty of evidence was moderate. CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis of 85 RCTs, iNPWT was associated with lower risks of overall, deep, and superficial SSI and several wound complications but potentially higher risks of skin blistering and device-related adverse events. These findings support selective rather than routine use, particularly in patients at elevated risk of incisional wound complications.
引用
- Patel S, Nischal SA, Kale KM, et al. Incisional Negative Pressure Wound Therapy for Prevention of Surgical Site Infection: A Systematic Review and Meta-Analysis. JAMA Surg. 2026. PMID: 42616534. doi:10.1001/jamasurg.2026.3516
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。